These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38862650)

  • 1. Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy.
    Mansoor H; Lee IXY; Lin MT; Ang HP; Xue YC; Krishaa L; Patil M; Koh SK; Tan HC; Zhou L; Liu YC
    Sci Rep; 2024 Jun; 14(1):13435. PubMed ID: 38862650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
    Teo CHY; Lin MT; Lee IXY; Koh SK; Zhou L; Goh DS; Choi H; Koh HWL; Lam AYR; Lim PS; Mehta JS; Kovalik JP; Coffman TM; Tan HC; Liu YC
    Diabetes; 2023 Jul; 72(7):932-946. PubMed ID: 36445944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.
    Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX
    Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.
    Cho YR; Lim JH; Kim MY; Kim TW; Hong BY; Kim YS; Chang YS; Kim HW; Park CW
    PLoS One; 2014; 9(1):e83204. PubMed ID: 24392081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-α Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride.
    He H; Liang M; Li L; Luo S; Fang X; He H; Xiao X; Wu H; Lin Z
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):54. PubMed ID: 32232349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
    Arima T; Uchiyama M; Nakano Y; Nagasaka S; Kang D; Shimizu A; Takahashi H
    Sci Rep; 2017 Dec; 7(1):17763. PubMed ID: 29259285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice.
    Guo C; Li M; Qi X; Lin G; Cui F; Li F; Wu X
    Sci Rep; 2016 Jul; 6():29753. PubMed ID: 27405815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEDF Attenuates Ocular Surface Damage in Diabetic Mice Model Through Its Antioxidant Properties.
    Liu X; Liu H; Lu X; Tombran-Tink J; Zhao S
    Curr Eye Res; 2021 Mar; 46(3):302-308. PubMed ID: 32862727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
    Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Deprivation Induces Dry Eye Through Inhibition of PPARα Expression in Corneal Epithelium.
    Tang L; Wang X; Wu J; Li SM; Zhang Z; Wu S; Su T; Lin Z; Chen X; Liao X; Bai T; Qiu Y; Reinach PS; Li W; Chen Y; Liu Z
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5494-5508. PubMed ID: 30658033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea.
    Liang W; Huang L; Whelchel A; Yuan T; Ma X; Cheng R; Takahashi Y; Karamichos D; Ma JX
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2217576120. PubMed ID: 36943878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical calcitriol application promotes diabetic corneal wound healing and reinnervation through inhibiting NLRP3 inflammasome activation.
    Wang Y; Wan L; Zhang Z; Li J; Qu M; Zhou Q
    Exp Eye Res; 2021 Aug; 209():108668. PubMed ID: 34144035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
    Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.
    Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y
    Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR
    Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.